Kimberly Brandt is a pharmacist who is specialized in Critical Care in Cincinnati, Ohio. Patients can reach her at 4777 E Galbraith Rd, Cincinnati or contact her on 513-745-1818. Active license number of Kimberly Brandt is 03337293 for Critical Care in Ohio. Kimberly Brandt is a licensed pharmacist who has demonstrated specialized knowledge and skill in the delivery of patient care services by pharmacists, as integral members of interprofessional teams, working to ensure the safe and effective use of medications in critically ill patients.
Complete Profile:
Kimberly Brandt speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Kimberly Brandt
Specialization:
Critical Care
Gender:
Female
Location:
4777 E Galbraith Rd, Cincinnati, Ohio, 45236-2725
Phone:
513-745-1818
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Kimberly Brandt are as mentioned below.
NPI Number:
1821683046
NPI Enumeration Date:
09 Mar, 2021
NPI Last Update On:
09 Mar, 2021
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Kimberly Brandt are as mentioned below.
Specialization
License Number
State
Status
Critical Care
03337293
Ohio
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
4777 E Galbraith Rd, Cincinnati, Ohio
Zip:
45236-2725
Phone Number:
--
Fax Number:
--
Patients can reach Kimberly Brandt at 4777 E Galbraith Rd, Cincinnati, Ohio or can call on phone at 513-745-1818.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.